Wang Jiguang (left), assistant professor at the division of life science, department of chemical and biological engineering, HKUST, and Professor Jiang Tao (right) from Beijing Tiantan Hospital, showing results of the clinical trial. Photo: Hong Kong University of Science and Technology

Breakthrough drug co-developed by Hong Kong research team offers hope of longer life to brain cancer sufferers

  • Researchers at Hong Kong University of Science and Technology say the drug, PLB-1001, can stall the effects of rare disease Secondary Glioblastoma
  • The drug showed signs of success in a three-month trial on patients whose cancer was resistant to chemotherapy
Topic |   Hong Kong cancer therapy

TOP PICKS

Wang Jiguang (left), assistant professor at the division of life science, department of chemical and biological engineering, HKUST, and Professor Jiang Tao (right) from Beijing Tiantan Hospital, showing results of the clinical trial. Photo: Hong Kong University of Science and Technology
READ FULL ARTICLE